Minh Tung Phung
Has grant
Assistant Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Frailty Trajectories and Racial/Ethnic Disparities in Survival among Older Ovarian Cancer Patients
Open Date: 2025-03-01
Close Date: 2026-02-01
Grant: Close
Ovarian cancer treatment outcomes by frailty status
Open Date: 2025-02-01
Close Date: 2026-01-01
Grant: Close
Optimizing a Risk Stratification Model for Ovarian Cancer
Open Date: 2024-04-01
Close Date: 2026-03-01
Grant: Close
Risk-reducing Salpingectomy for Ovarian Cancer Precision Prevention
Open Date: 2024-01-01
Close Date: 2026-01-01
Grant: Close
Early onset breast cancer and research on the environment
Open Date: 2022-07-01
Close Date: 2024-06-30
Articles (11)
Year:
2026
With evidence that salpingectomy is effective in preventing high-grade serous carcinoma, it is time to consider offering this procedure to people at higher-than-average lifetime risk for ovarian cancer, despite not having a pathogenic genetic variant that increases the risk for ovarian cancer. This targeted approach has potential to be effective at reducing ovarian cancer incidence, and unlike opportunistic salpingectomy, it is focused on people with an increased lifetime risk of ovarian cancer. However, the acceptability of this approach within the population of potential patients remains unknown. We conducted an online survey of adults in British Columbia, Canada, who were defined as “at risk” for ovarian cancer (i.e., people born with ovaries). Participants completed a questionnaire on demographics, ovarian cancer risk and protective factors, concerns about risk-reducing salpingectomy (RSS), and the risk they considered high enough to warrant RRS. We included 211 participants. Among these participants, 42% (n = 88) indicated that they would consider RRS at any lifetime risk or any risk above the population average. Another 20 participants chose risks between 1.5% and 4% for a cumulative 51% of the sample choosing risks below thresholds for oophorectomy. In contrast, 6% (n = 12) indicated that they would not consider the procedure at any risk level. None of the factors collected were associated with the likelihood that a person would find RRS acceptable. Overall, our participants showed broad interest in RRS as an ovarian cancer prevention strategy. These results suggest that there would likely be uptake if RRS was offered. Significance: This study found that many participants were willing to consider RRS to prevent ovarian cancer. Further research on RRS should be undertaken to understand how this can be best used for ovarian cancer prevention.
Year:
2025
Supplementary Table 1. Logistic regression analysis of factors associated with accepting risk-reducing surgery (RRS) for ovarian cancer when lifetime risk is less than 4% compared to greater or equal to 4%, using complete case analysis
Year:
2025
With evidence that salpingectomy is effective in preventing high-grade serous carcinoma, it is time to consider offering this procedure to people at higher-than-average lifetime risk for ovarian cancer, despite not having a pathogenic genetic variant that increases the risk for ovarian cancer. This targeted approach has potential to be effective at reducing ovarian cancer incidence, and unlike opportunistic salpingectomy, it is focused on people with an increased lifetime risk of ovarian cancer. However, the acceptability of this approach within the population of potential patients remains unknown. We conducted an online survey of adults in British Columbia, Canada, who were defined as “at risk” for ovarian cancer (i.e., people born with ovaries). Participants completed a questionnaire on demographics, ovarian cancer risk and protective factors, concerns about risk-reducing salpingectomy (RSS), and the risk they considered high enough to warrant RRS. We included 211 participants. Among these participants, 42% ( n = 88) indicated that they would consider RRS at any lifetime risk or any risk above the population average. Another 20 participants chose risks between 1.5% and 4% for a cumulative 51% of the sample choosing risks below thresholds for oophorectomy. In contrast, 6% ( n = 12) indicated that they would not consider the procedure at any risk level. None of the factors collected were associated with the likelihood that a person would find RRS acceptable. Overall, our participants showed broad interest in RRS as an ovarian cancer prevention strategy. These results suggest that there would likely be uptake if RRS was offered. Significance: This study found that many participants were willing to consider RRS to prevent ovarian cancer. Further research on RRS should be undertaken to understand how this can be best used for ovarian cancer prevention.
Year:
2025
Supplementary Table 1. Logistic regression analysis of factors associated with accepting risk-reducing surgery (RRS) for ovarian cancer when lifetime risk is less than 4% compared to greater or equal to 4%, using complete case analysis
Year:
2025
Logistic regression analysis of factors associated with accepting risk-reducing surgery (RRS) for ovarian cancer when the lifetime risk is less than 4%, compared with greater than or equal to 4%, using hot deck imputation
Year:
2025
Year:
2024
Among Arab-American women in Michigan, rates of cervical cancer screening are lower than those in non-Hispanic White and Black women in the state. A deep understanding of the Arab community’s perspective on cervical cancer screening is needed to address the disparity in rates across populations in Michigan. Arab and Chaldean women across Michigan were invited to participate in Zoom-based focus groups to understand the attitudes, acceptability, and barriers of cervical cancer screening among this population. Four focus groups with a total of 19 women aged 30 to 61 were conducted. The focus groups were conducted in English, Arabic, or both languages. The guided discussion was focused on knowledge of cervical cancer and Human papillomavirus (HPV) and its transmission, attitudes towards HPV vaccination, and attitudes towards cervical cancer screening. HPV self-sampling as an alternative to traditional provider-based screening was specifically discussed as this has been proposed as a way to increase screening in hard-to-reach populations. The conversations revealed insights related to barriers at the individual and community levels for screening and vaccination, attitudes towards preventive health care including screening, a need for accessible women’s health literature, and health education. The women also discussed vaccine hesitancy related to HPV and COVID-19, suggesting a need for targeted community interventions.
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Collaborators (12)
Britton Trabert
Associate Professor
University of Utah
Maria Jose Garcia
Instituto de Investigaciones Biomédicas Alberto Sols
Jihyoun Jeon
University of Michigan
Hui Shen
Van Andel Institute
Karen McLean
Professor
Roswell Park Comprehensive Cancer Center
Rafael Meza
Distinguished Scientist
University of Michigan
Gillian Hanley
Associate Professory
The University of British Columbia
Alice Lee
Associate Professor
California State University Fullerton
Hoda Anton-Culver
Professor and Chair
University of California, Irvine
David G. Huntsman
The University of British Columbia
Fuchsia Howard
Associate Professor
The University of British Columbia
Susan Ramus
Professor of Molecular Oncology
University of New South Wales
Make your next move.
Prepare your application
Review drafts before you send them.